These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8889281)

  • 1. The study of neurotransmitter interactions using positron emission tomography and functional coupling.
    Schloesser R; Simkowitz P; Bartlett EJ; Wolkin A; Smith GS; Dewey SL; Brodie JD
    Clin Neuropharmacol; 1996 Oct; 19(5):371-89. PubMed ID: 8889281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of neurotransmitter interactions with PET and SPECT by pharmacological challenge paradigms].
    Schlösser R
    Nervenarzt; 2000 Jan; 71(1):9-18. PubMed ID: 10695027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo imaging of neurotransmitter systems using radiolabeled receptor ligands.
    Kegeles LS; Mann JJ
    Neuropsychopharmacology; 1997 Nov; 17(5):293-307. PubMed ID: 9348545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurotransmission in human brains measured by positron emission tomography (PET)].
    Yanai K
    Nihon Yakurigaku Zasshi; 1997 Jun; 109(6):259-70. PubMed ID: 9253773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies in Alzheimer patients with positron emission tomography.
    Nordberg A
    Behav Brain Res; 1993 Nov; 57(2):215-24. PubMed ID: 7906947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional imaging studies: linking mind and basic neuroscience.
    Shulman RG
    Am J Psychiatry; 2001 Jan; 158(1):11-20. PubMed ID: 11136626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomography--a tool for identifying the effects of alcohol dependence on the brain.
    Wong DF; Maini A; Rousset OG; Brasić JR
    Alcohol Res Health; 2003; 27(2):161-73. PubMed ID: 15303627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug development for neurodegenerative diseases: role of PET.
    Rinne JO
    Ann Med; 1999 Dec; 31(6):444-9. PubMed ID: 10680860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacology--in vivo neurochemistry and pharmacology.
    Grasby P; Malizia A; Bench C
    Br Med Bull; 1996 Jul; 52(3):513-26. PubMed ID: 8949254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging.
    Magistretti PJ; Pellerin L
    Philos Trans R Soc Lond B Biol Sci; 1999 Jul; 354(1387):1155-63. PubMed ID: 10466143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What are we measuring with PET?
    Morgan AE; Brodie JD; Dewey SL
    Q J Nucl Med; 1998 Sep; 42(3):151-7. PubMed ID: 9796363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Visualization of neurotransmitter receptors in the living human brain by position emission tomography (PET)].
    Yanai K; Watanabe T
    Nihon Yakurigaku Zasshi; 1994 Feb; 103(2):49-58. PubMed ID: 8112689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-associated functional impairments of specific neurotransmitter systems: detection by pharmacological brain metabolism studies and criteria for design of human investigations.
    Soncrant TT
    Int J Clin Pharmacol Res; 1990; 10(1-2):27-47. PubMed ID: 1974889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Imaging brain function with autoradiography and positron emission tomography].
    Kato M; Hosokawa S; Kuwabara Y
    Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1182-91. PubMed ID: 1972583
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional imaging of the brain in the evaluation of drug response and its application to the study of aging.
    Bryant CA; Jackson SH
    Drugs Aging; 1998 Sep; 13(3):211-22. PubMed ID: 9789725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The advantages and limitations of brain function analyses by PET].
    Kato M; Taniwaki T; Kuwabara Y
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1274-6. PubMed ID: 11464477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET physiological measurements using constant infusion.
    Carson RE
    Nucl Med Biol; 2000 Oct; 27(7):657-60. PubMed ID: 11091108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients.
    Bartlett EJ; Brodie JD; Simkowitz P; Schlösser R; Dewey SL; Lindenmayer JP; Rusinek H; Wolkin A; Cancro R; Schiffer W
    Am J Psychiatry; 1998 Mar; 155(3):337-43. PubMed ID: 9501742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurotransmitter systems in the human brain studied by positron emission tomography].
    Shinotoh H
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1313-5. PubMed ID: 9128390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography studies of abnormal glucose metabolism in schizophrenic illness.
    Buchsbaum MS
    Clin Neurosci; 1995; 3(2):122-30. PubMed ID: 7583618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.